This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
2 Oct 2017

Construction starts for Sartorius' new Cell Culture Technology Centre

Ground-breaking ceremony for Sartorius Stedim Cellca.

The 30-million-euro investment will accommodate the growing needs of customers.

Sartorius Stedim Cellca is building a new 30-million-euro Cell Culture Technology Center at Science Park III in Eselsberg situated at the northwestern scientific hub of the city of Ulm, Germany. Hugo de Wit, Managing Director, and Joachim Kreuzburg, CEO and Executive Board Chairman of Sartorius AG, symbolically broke ground in the presence of around 100 guests, marking the official start of construction work. “This is a significant step for Sartorius Stedim Cellca and our staff to soon be able to work in an advanced new complex. We are very proud of this as the new, modern facility will enable us to continue accommodating the growing needs of our customers in the future as well,” said de Wit.

So far, Sartorius Stedim Cellca has been working in a rented building in Laupheim. The new laboratory and office complex will approximately double the company’s space and is scheduled to be completed by the end of 2019. In addition, relocation to this zone will provide closer proximity to universities and research institutes that are based in Ulm’s Science Park. In addition, this move to the new facility, which is conveniently accessible by various transportation routes between the large cities of Stuttgart and Munich, will make it even easier for international customers to visit the company. Sartorius Stedim Cellca purchased the property of more than 6,000 m2 at Science Park III back in November 2016 and can, therefore, expand its Cell Culture Technology Center by a further 5,000 m2 as needed.

Sartorius Stedim Cellca develops cell lines and protein production processes, licenses technologies for the production of proteins and offers cell culture media. The company has been a part of the biopharma equipment supplier Sartorius Stedim Biotech since 2015 and currently employs around 90 people. Over the medium term, the company plans to extend its workforce to more than 120 people.

Mentioned Companies
Sartorius Stedim Biotech
View company profile

Related News